香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不對因本公告全部或任何部份內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 朱健 董事長 中國上海 2025年12月9日 國泰海通證券股份有限公司 Guotai Haitong Securities Co., Ltd. （於中華人民共和國註冊成立的股份有限公司） （股份代號：02611） 海外監管公告 本公告乃由國泰海通證券股份有限公司（「本公司」）根據香港聯合交易所有限公司 證券上市規則第13.10B條作出。 茲載列本公司於上海證券交易所網站發佈之《國泰海通證券股份有限公司關於公 司實際控制人之一致行動人權益變動的提示性公告》，僅供參閱。 承董事會命 國泰海通證券股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次权益变动为公司实际控制人上海国际集团有限公司（以下简称国际集团） 的一致行动人上海国际集团资产经营有限公司（以下简称资产经营公司）将其所持 公司 931, ...

证券代码：601211 证券简称：国泰海通 公告编号：2025-106 国泰海通证券股份有限公司 关于公司实际控制人之一致行动人 权益变动的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次权益变动为公司实际控制人上海国际集团有限公司（以下简称国际集团） 的一致行动人上海国际集团资产经营有限公司（以下简称资产经营公司）将其所持 公司 931,505 股 A 股股份无偿划转至国际集团全资子公司上海国际集团资产管理有 限公司（以下简称国际集团资管公司）名下。本次权益变动不会使国际集团及其一 致行动人所持公司股份合计数量发生变化。 近日，国泰海通证券股份有限公司（以下简称公司）接到国际集团资管公司书 面通知，国际集团资管公司下属全资子公司资产经营公司拟将其所持有的公司 931,505 股 A 股（约占公司股份总数的 0.01%）无偿划转至国际集团资管公司名下。 现将有关情况公告如下： 一、本次权益变动基本情况 近日，因内部管理工作需要，国际集团的一致行动人资产经营公司拟将其持有 的公司 931,505 ...

格隆汇12月9日丨国泰海通(601211.SH)公布，近日，公司接到国际集团资管公司书面通知，国际集团资 管公司下属全资子公司资产经营公司拟将其所持有的公司931,505股A股（约占公司股份总数的0.01%） 无偿划转至国际集团资管公司名下。 ...

12月9日，国泰君安稳定币兑换数字人民币的服务通道正式开启。在数字资产从"小众炒作"走向"全民合规"的转型期，这一举措不仅标志着万亿级国家级政 策红利从"政策承诺"迈入"实际兑付"的关键阶段，更以国家信用为背书，为普通人搭建起通往合规数字金融世界的安全桥梁，与上海、浙江等地推动数字资 产合规交易的实践方向高度契合。 这种透明化彻底终结了过去"靠传闻参与、凭运气获利"的非理性数字资产参与模式。兑换后的数字人民币作为法定货币，可直接对接合规数字场景——既包 括公交出行等民生领域，也涵盖符合《发行NFT数字藏品合规操作指引》的数字藏品交易，既规避了虚拟货币交易的法律风险，又让数字资产从"高风险炒 作标的"回归"实用价值载体"，这种"看得见、靠得住"的安全感，让普通人对数字金融的信心持续升温。 分档兑付：合规框架下的效率与公平共生 此次采用的"持币规模关联审核时序"阶梯模式，是合规数字金融服务的典型实践。"持币越多、审核越早、落地越快"的差异化安排，既满足了大额资产对流 动性的合理需求，更通过科学分档实现错峰办理，从根源上规避了系统拥堵风险，构建起"大额高效转换、小额有序推进"的合规格局，让不同规模参与者都 能在规则 ...

1. Report Industry Investment Rating No information provided in the report. 2. Core Viewpoints The report presents the daily data of stock index futures, including the closing price, trading volume, turnover, open interest, basis, and the positions of major seats for different contracts of IM, IF, IC, and IH. It also shows the intraday trends and historical basis data for each type of futures. 3. Summary by Relevant Catalogs IM Futures - **Daily Market Quotes**: The closing prices of IM contracts decreased, with the main contract IM2512 closing at 7347.80, down 0.53%. The total trading volume of the four contracts was 140,871 hands, down 29,557 hands from the previous day, and the total open interest was 360,007 hands, up 3,359 hands. The main contract was at a discount of 32.78 points, up 9.87 points from the previous day, with an annualized basis rate of -14.8% [3][5]. - **Intraday Trends**: Charts show the intraday trends of IM and the relationship between trading volume and open interest [6]. - **Daily Basis**: Data on the basis, annualized transfer cost, and dividend impact of each contract are provided, with negative values indicating profitable transfer [10][12]. - **Daily Positions**: The positions of major seats in different contracts are presented, including the trading volume, long positions, and short positions of top - ranking members [17][19][21]. IF Futures - **Daily Market Quotes**: The closing prices of IF contracts decreased, with the main contract IF2512 closing at 4583.20, down 0.75%. The total trading volume of the four contracts was 99,497 hands, down 21,031 hands from the previous day, and the total open interest was 269,295 hands, down 3,493 hands. The main contract was at a discount of 15.02 points, down 6.47 points from the previous day, with an annualized basis rate of -10.88% [22][23]. - **Intraday Trends**: Charts show the intraday trends of IF and the relationship between trading volume and open interest [24]. - **Daily Basis**: Data on the basis, annualized transfer cost, and dividend impact of each contract are provided [27][30][33]. - **Daily Positions**: The positions of major seats in different contracts are presented, including the trading volume, long positions, and short positions of top - ranking members [37][39][41]. IC Futures - **Daily Market Quotes**: The closing prices of IC contracts decreased, with the main contract IC2512 closing at 7094.40, down 0.79%. The total trading volume of the four contracts was 95,795 hands, down 11,252 hands from the previous day, and the total open interest was 249,613 hands, up 902 hands. The main contract was at a discount of 26.93 points, up 1.44 points from the previous day, with an annualized basis rate of -12.59% [43][44]. - **Intraday Trends**: Charts show the intraday trends of IC and the relationship between trading volume and open interest [45]. - **Daily Basis**: Data on the basis, annualized transfer cost, and dividend impact of each contract are provided [48][50][52]. - **Daily Positions**: The positions of major seats in different contracts are presented, including the trading volume, long positions, and short positions of top - ranking members [57][59][61]. IH Futures - **Daily Market Quotes**: The closing prices of IH contracts decreased, with the main contract IH2512 closing at 2991.60, down 0.88%. The total trading volume of the four contracts was 39,137 hands, down 10,757 hands from the previous day, and the total open interest was 92,368 hands, down 3,696 hands. The main contract was at a discount of 6.36 points, down 2 points from the previous day, with an annualized basis rate of -7.05% [63][64]. - **Intraday Trends**: Charts show the intraday trends of IH and the relationship between trading volume and open interest [66]. - **Daily Basis**: Data on the basis, annualized transfer cost, and dividend impact of each contract are provided [68][71][74]. - **Daily Positions**: The positions of major seats in different contracts are presented, including the trading volume, long positions, and short positions of top - ranking members [78][80].

Core Viewpoint - The event marks the 10th anniversary of the Gaobai Relay Race and the launch of the 2025 strategic plan, emphasizing the integration of sports and education as part of a broader health initiative for students [1][6]. Group 1: Event Overview - The Gaobai Relay Race is a key component of the 2025 Shanghai student sports activities and serves as a benchmark event for promoting student health [3]. - The final event attracted 100 university teams and nearly 1,300 young athletes from seven major regions and cities across the country [4]. Group 2: Company Involvement - Guotai Junan received the "Dream Partner Award" for its comprehensive support of the Gaobai Relay Race, aligning with national strategies for sports industry development [6]. - The company aims to enhance its brand image by promoting financial knowledge and responsible investment concepts among students and citizens through various engaging activities [8]. Group 3: Educational Initiatives - The company has introduced innovative educational projects, such as the "MBTI Investment Personality Test" and interactive games, to make financial knowledge accessible to the younger generation [11]. - Initiatives like the "Campus Challenge Plan" and the "Financial Knowledge Relay Challenge" aim to provide personalized financial education experiences for youth [11]. Group 4: Commitment to Social Responsibility - Guotai Junan has a long-standing commitment to educational philanthropy, having established multiple Hope Primary Schools and scholarship programs across various educational levels [14]. - The company actively participates in significant Shanghai events, integrating high-quality brand building with the city's development and contributing to its cultural soft power [16].

中国经济网北京12月9日讯奥浦迈(688293.SH)昨日晚间披露公告，上海证券交易所并购重组审核委员会2025年第20次审议会议 于12月8日召开，审议结果显示，公司发行股份购买资产符合重组条件和信息披露要求。本次交易尚需经中国证券监督管理委 员会同意注册后方可实施。本次交易能否完成注册以及最终取得完成注册的时间均存在不确定性。 重组委会议现场问询的主要问题： 1.请上市公司代表结合上市公司和标的公司业务布局、目前主要收入覆盖疾病领域、境内外收入结构差异等，说明协同效应的 实现方式以及风险揭示的充分性。请独立财务顾问代表发表明确意见。 2.请上市公司代表结合境外市场药物临床前CRO业务的市场竞争格局、标的公司的竞争优劣势、境外销售资源投入、客户结构 等情况，说明标的公司境外销售收入确认的合规性以及预测期境外业务增长的可持续性。请独立财务顾问代表、会计师代表和 评估师代表发表明确意见。 需进一步落实事项： 截至2025年6月30日，上市公司总股本为113,548,754股。上市公司控股股东为肖志华，实际控制人为肖志华、HEYUNFEN(贺 芸芬)夫妇。肖志华直接持有上市公司24.92%股份，肖志华、HEYUN ...

Core Insights - The National Healthcare Security Administration (NHSA) has released the updated National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance drug catalog, adding 114 new drugs, significantly enhancing coverage in key areas such as oncology [1][2] - The report highlights a successful establishment of a clear direction for supporting genuine and differentiated innovation through strategic purchasing [1] - The commercial health insurance drug catalog has been introduced, complementing the basic medical insurance and laying the foundation for a multi-tiered medical security system [3] Group 1: Drug Catalog Adjustments - The recent adjustment added 114 new drugs, including 50 class 1 innovative drugs, with an overall negotiation success rate of 88%, up from 76% in 2024 [2] - The total number of drugs in the catalog has increased to 3,253, with significant improvements in coverage for oncology, chronic diseases, mental illnesses, rare diseases, and pediatric medications [2] Group 2: Financial Implications - During the 14th Five-Year Plan period, the cumulative expenditure of the medical insurance fund exceeded 13 trillion yuan, benefiting nearly 20 billion patient visits [1] - Over the past seven years, 835 new drugs have been included in the medical insurance payment scope, with 149 of them being innovative drugs, and approximately 80% of innovative drugs being included within two years of market launch [1] Group 3: Commercial Health Insurance Developments - The first version of the commercial health insurance innovative drug catalog includes 19 drugs, focusing on high innovation, significant clinical value, and patient benefits beyond basic insurance coverage [3] - The introduction of the commercial health insurance catalog is expected to clarify the boundaries of basic medical insurance and promote the differentiated development of commercial health insurance [3]

Core Viewpoint - The company, Jinqiao Information, has received approval from the Shanghai Stock Exchange for its application to issue A-shares to specific investors, pending final approval from the China Securities Regulatory Commission (CSRC) [1] Group 1: Issuance Details - The total amount to be raised from the issuance is not to exceed 615.38 million yuan, which will be allocated to projects including the upgrade of smart space solutions, AI research and development for industry applications, and replenishing working capital [1][2] - The issuance will involve no more than 35 specific investors, including qualified institutional investors such as securities investment fund management companies, securities companies, trust companies, financial companies, insurance companies, and qualified foreign institutional investors [2] - The pricing benchmark for the issuance will be set at 80% of the average trading price of the company's shares over the 20 trading days prior to the issuance date [2] Group 2: Shareholder Impact - The number of shares to be issued will not exceed 20% of the company's total share capital prior to the issuance, amounting to a maximum of 73,021,505 shares [3] - The controlling shareholder, Jin Guopei, currently holds 18.25% of the shares, and after the issuance, this percentage is expected to decrease to a minimum of 15.21% [3] - Measures will be taken to ensure the stability of the company's control, including limiting the number of shares that a single investor can subscribe to and requiring commitments from investors not to seek control of the company [4][5]

文/瑞财经 许淑敏 12月6日这一天，中国证券业协会第八次会员大会举行。 在规模实力方面，107家证券公司总资产14.5万亿元，净资产3.3万亿元，四年多来增长分别超过60%和 40%。证券公司客户超过2.4亿，增长26%。 眼下，整个行业进入"十五五"的关键阶段，有了新的发展要求。吴清称，"十五五"也是我们乘势而上， 全面深化资本市场改革、加快打造一流投行和投资机构的战略机遇期。 作为协会会长，朱健重任在肩。 不过，从2016年12月开始，他进入国泰君安证券，担任副总裁，再到2020年10月调任上海银行行长。 2023年12月，他回归国泰君安证券任董事长。 今年3月，国泰君安与海通证券完成合并成为国泰海通，朱健担任董事长一职。此番朱健担任中证协会 长职务，属于兼职工作。 朱健兼职中证协会长，一些信号正在释出。 中国证监会主席吴清在大会上提到，过去四年多来，证券行业发生了深刻变化，呈现出良好发展态势。 此次大会，选举产生了协会新一届领导机构。颇令人意外的是，国泰海通董事长朱健当选为新一届会 长。 要知道，以往中证协会长多是直接来自监管部门。像是上一届会长赵山忠，曾任重庆证监局党委书记、 局长。 而现年54岁的 ...